001 | 144505 | ||
005 | 20240229112627.0 | ||
024 | 7 | _ | |a 10.1093/jn/nxz156 |2 doi |
024 | 7 | _ | |a pmid:31396627 |2 pmid |
024 | 7 | _ | |a 0022-3166 |2 ISSN |
024 | 7 | _ | |a 1541-6100 |2 ISSN |
024 | 7 | _ | |a altmetric:64919662 |2 altmetric |
037 | _ | _ | |a DKFZ-2019-01953 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Imamura, Fumiaki |b 0 |
245 | _ | _ | |a Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study. |
260 | _ | _ | |a Bethesda, Md. |c 2019 |b Oxford University Press |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1573821026_10710 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 149(11):1985-1993 |
520 | _ | _ | |a Beverage consumption is a modifiable risk factor for type 2 diabetes (T2D), but there is insufficient evidence to inform the suitability of substituting 1 type of beverage for another.The aim of this study was to estimate the risk of T2D when consumption of sugar-sweetened beverages (SSBs) was replaced with consumption of fruit juice, milk, coffee, or tea.In the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study of 8 European countries (n = 27,662, with 12,333 cases of incident T2D, 1992-2007), beverage consumption was estimated at baseline by dietary questionnaires. Using Prentice-weighted Cox regression adjusting for other beverages and potential confounders, we estimated associations of substituting 1 type of beverage for another on incident T2D.Mean ± SD of estimated consumption of SSB was 55 ± 105 g/d. Means ± SDs for the other beverages were as follows: fruit juice, 59 ± 101 g/d; milk, 209 ± 203 g/d; coffee, 381 ± 372 g/d; and tea, 152 ± 282 g/d. Substituting coffee for SSBs by 250 g/d was associated with a 21% lower incidence of T2D (95% CI: 12%, 29%). The rate difference was -12.0 (95% CI: -20.0, -5.0) per 10,000 person-years among adults consuming SSBs ≥250 g/d (absolute rate = 48.3/10,000). Substituting tea for SSBs was estimated to lower T2D incidence by 22% (95% CI: 15%, 28%) or -11.0 (95% CI: -20.0, -2.6) per 10,000 person-years, whereas substituting fruit juice or milk was estimated not to alter T2D risk significantly.These findings indicate a potential benefit of substituting coffee or tea for SSBs for the primary prevention of T2D and may help formulate public health recommendations on beverage consumption in different populations. |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Schulze, Matthias B |b 1 |
700 | 1 | _ | |a Sharp, Stephen J |b 2 |
700 | 1 | _ | |a Guevara, Marcela |b 3 |
700 | 1 | _ | |a Romaguera, Dora |b 4 |
700 | 1 | _ | |a Bendinelli, Benedetta |b 5 |
700 | 1 | _ | |a Salamanca-Fernández, Elena |b 6 |
700 | 1 | _ | |a Ardanaz, Eva |b 7 |
700 | 1 | _ | |a Arriola, Larraitz |b 8 |
700 | 1 | _ | |a Aune, Dagfinn |b 9 |
700 | 1 | _ | |a Boeing, Heiner |b 10 |
700 | 1 | _ | |a Dow, Courtney |b 11 |
700 | 1 | _ | |a Fagherazzi, Guy |b 12 |
700 | 1 | _ | |a Franks, Paul W |b 13 |
700 | 1 | _ | |a Freisling, Heinz |b 14 |
700 | 1 | _ | |a Jakszyn, Paula |b 15 |
700 | 1 | _ | |a Kaaks, Rudolf |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |b 16 |u dkfz |
700 | 1 | _ | |a Khaw, Kay-Tee |b 17 |
700 | 1 | _ | |a Kühn, Tilman |0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |b 18 |u dkfz |
700 | 1 | _ | |a Mancini, Francesca R |b 19 |
700 | 1 | _ | |a Masala, Giovanna |b 20 |
700 | 1 | _ | |a Chirlaque, Maria-Dolores |b 21 |
700 | 1 | _ | |a Nilsson, Peter M |b 22 |
700 | 1 | _ | |a Overvad, Kim |b 23 |
700 | 1 | _ | |a Pala, Valeria M |b 24 |
700 | 1 | _ | |a Panico, Salvatore |b 25 |
700 | 1 | _ | |a Perez-Cornago, Aurora |b 26 |
700 | 1 | _ | |a Quirós, Jose R |b 27 |
700 | 1 | _ | |a Ricceri, Fulvio |b 28 |
700 | 1 | _ | |a Rodríguez-Barranco, Miguel |b 29 |
700 | 1 | _ | |a Rolandsson, Olov |b 30 |
700 | 1 | _ | |a Sluijs, Ivonne |b 31 |
700 | 1 | _ | |a Stepien, Magdalena |b 32 |
700 | 1 | _ | |a Spijkerman, Annemieke M W |b 33 |
700 | 1 | _ | |a Tjønneland, Anne |b 34 |
700 | 1 | _ | |a Tong, Tammy Y N |b 35 |
700 | 1 | _ | |a Tumino, Rosario |b 36 |
700 | 1 | _ | |a Vissers, Linda E T |b 37 |
700 | 1 | _ | |a Ward, Heather A |b 38 |
700 | 1 | _ | |a Langenberg, Claudia |b 39 |
700 | 1 | _ | |a Riboli, Elio |b 40 |
700 | 1 | _ | |a Forouhi, Nita G |b 41 |
700 | 1 | _ | |a Wareham, Nick J |b 42 |
773 | _ | _ | |a 10.1093/jn/nxz156 |g p. nxz156 |0 PERI:(DE-600)1469429-3 |n 11 |p 1985-1993 |t The journal of nutrition |v 149 |y 2019 |x 1541-6100 |
909 | C | O | |o oai:inrepo02.dkfz.de:144505 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2019 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NUTR : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l Epidemiologie von Krebserkrankungen |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|